Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Och-Ziff Capital Management (OZM) 2010 Returns

Och-Ziff Capital Management (OZM) provided preliminary estimates for its December and 2010 returns in various funds:

Och-Ziff Capital Management Group LLC (NYSE:OZM)

December 2010
OZ Master Fund, Ltd. 0.78% 8.44%
OZ Europe Master Fund, Ltd. 1.07% 7.23%
OZ Asia Master Fund, Ltd. 0.94% 10.08%
OZ Global Special Investments 1.58% 13.16%

Och-Ziff Capital Management managed an estimated $27.6 Billion (unaudited assets under management) at the end of 2010.

Och-Ziff Capital Management Group LLC is a global asset management firm. It has offices in New York, London, Hong Kong, Mumbai and Beijing, managing various funds globally. OZM attracted $2.6 Billion in new capital through the first 9 months of 2010. Their Master Fund has around $19 Billion in AUM.

Previously we reported that Ken Griffin’s Citadel returned about 10% in 2010 and David Einhorn’s Greenlight Capital returned 15.9%.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.